Funding winter and corporate governance woes separated the men from the boys in the country’s startup space in 2023 that saw funds into the segment tapering to just around $8 billion. All said, investors are hopeful of strong growth of the maturing startup ecosystem in the new year. Edtech and health tech segments that grew exponentially during the pandemic plunged into an abyss of financial uncertainties, with several firms shuttering their business, and valuation of prominent players like BYJU’S and PharmEasy plummeting 85-90 per cent.
Subscribe To Our Free Newsletter |